These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 9840921

  • 1. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.
    Kondo S, Shinomura Y, Kanayama S, Higashimoto Y, Kiyohara T, Zushi S, Kitamura S, Ueyama H, Matsuzawa Y.
    Oncogene; 1998 Nov 19; 17(20):2585-91. PubMed ID: 9840921
    [Abstract] [Full Text] [Related]

  • 2. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M, Nakashima S, Banno Y, Yamakawa H, Takenaka K, Shinoda J, Nishimura Y, Sakai N, Nozawa Y.
    Oncogene; 2000 Jul 20; 19(31):3508-20. PubMed ID: 10918609
    [Abstract] [Full Text] [Related]

  • 3. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
    Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H.
    Oncogene; 2000 Nov 16; 19(48):5477-86. PubMed ID: 11114725
    [Abstract] [Full Text] [Related]

  • 4. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL.
    Rashmi R, Kumar S, Karunagaran D.
    Carcinogenesis; 2005 Apr 16; 26(4):713-23. PubMed ID: 15661804
    [Abstract] [Full Text] [Related]

  • 5. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY, Stein CA.
    Clin Cancer Res; 1997 Nov 16; 3(11):2039-46. PubMed ID: 9815595
    [Abstract] [Full Text] [Related]

  • 6. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.
    Lebedeva I, Rando R, Ojwang J, Cossum P, Stein CA.
    Cancer Res; 2000 Nov 01; 60(21):6052-60. PubMed ID: 11085527
    [Abstract] [Full Text] [Related]

  • 7. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
    Kitamura S, Kondo S, Shinomura Y, Kanayama S, Miyazaki Y, Kiyohara T, Hiraoka S, Matsuzawa Y.
    Br J Cancer; 2000 Sep 01; 83(5):668-73. PubMed ID: 10944610
    [Abstract] [Full Text] [Related]

  • 8. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR, Fletcher B, Page C, Hu C, Nunez G, Baker V.
    Gynecol Oncol; 1998 Sep 01; 70(3):398-403. PubMed ID: 9790794
    [Abstract] [Full Text] [Related]

  • 9. BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells.
    Tong QS, Zheng LD, Wang L, Liu J, Qian W.
    BMC Cancer; 2004 Jul 12; 4():33. PubMed ID: 15248898
    [Abstract] [Full Text] [Related]

  • 10. Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL and Bcl-2.
    Simonian PL, Grillot DA, Nuñez G.
    Oncogene; 1997 Oct 09; 15(15):1871-5. PubMed ID: 9362454
    [Abstract] [Full Text] [Related]

  • 11. Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax.
    Shinoura N, Yoshida Y, Asai A, Kirino T, Hamada H.
    Oncogene; 1999 Oct 07; 18(41):5703-13. PubMed ID: 10523849
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
    Vilenchik M, Raffo AJ, Benimetskaya L, Shames D, Stein CA.
    Cancer Res; 2002 Apr 01; 62(7):2175-83. PubMed ID: 11929841
    [Abstract] [Full Text] [Related]

  • 15. Expression and role of Bcl-xL in human hepatocellular carcinomas.
    Takehara T, Liu X, Fujimoto J, Friedman SL, Takahashi H.
    Hepatology; 2001 Jul 01; 34(1):55-61. PubMed ID: 11431734
    [Abstract] [Full Text] [Related]

  • 16. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
    Schmitt E, Sané AT, Steyaert A, Cimoli G, Bertrand R.
    Biochem Cell Biol; 1997 Jul 01; 75(4):301-14. PubMed ID: 9493953
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli.
    Taylor JK, Zhang QQ, Monia BP, Marcusson EG, Dean NM.
    Oncogene; 1999 Aug 05; 18(31):4495-504. PubMed ID: 10442640
    [Abstract] [Full Text] [Related]

  • 18. Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis.
    Zhang H, Taylor J, Luther D, Johnston J, Murray S, Wyatt JR, Watt AT, Koo S, York-DeFalco C, Stecker K, Dean NM.
    J Pharmacol Exp Ther; 2003 Oct 05; 307(1):24-33. PubMed ID: 12893848
    [Abstract] [Full Text] [Related]

  • 19. Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma.
    Mohiuddin I, Cao X, Fang B, Nishizaki M, Smythe WR.
    Cancer Gene Ther; 2001 Aug 05; 8(8):547-54. PubMed ID: 11571532
    [Abstract] [Full Text] [Related]

  • 20. Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides.
    Lebedeva I, Raffo A, Rando R, Ojwang J, Cossum P, Stein CA.
    J Urol; 2001 Aug 05; 166(2):461-9. PubMed ID: 11458048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.